<img width="4000" height="4000" data-src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo lazyload" alt="BestBull" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 4000px; --smush-placeholder-aspect-ratio: 4000/4000;" /><noscript><img width="4000" height="4000" src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo" alt="BestBull" decoding="async" />

<img width="4000" height="4000" src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="sticky-logo" alt="BestBull" decoding="async" />

<img width="4000" height="4000" data-src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo lazyload" alt="BestBull" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 4000px; --smush-placeholder-aspect-ratio: 4000/4000;" /><noscript><img width="4000" height="4000" src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo" alt="BestBull" decoding="async" />

<img width="4000" height="4000" src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="sticky-logo" alt="BestBull" decoding="async" />

<img width="4000" height="4000" data-src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo lazyload" alt="BestBull" decoding="async" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 4000px; --smush-placeholder-aspect-ratio: 4000/4000;" /><noscript><img width="4000" height="4000" src="https://bestbull.co.in/wp-content/uploads/2023/05/logo.png" class="default-logo" alt="BestBull" decoding="async" />

Zydus Lifesciences’ venture arm invests in Illexcor Therapeutics for sickle cell disease therapies

March 12, 2025
Uncategorized

Shares of Zydus Lifesciences Ltd ended at ₹889.00, down by ₹10.90, or 1.21%, on the BSE.

Leave a ReplyCancel Reply